Immunomedics
is a biopharmaceutical company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer... Read moreImmunomedics
is a biopharmaceutical company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer... Read more
CEO
Add
News
Mar 27, 2023
centralcharts
Press Release: Immunomedics : Everest Medicines Receives Full Upfront Payment from Gilead for Trodelvy-Related Transaction, Boosting Pro Forma Cash Reserves
Feb 23, 2023
Law 360
Immunomedics: Immunomedics' $40M Deal Over Data Scandal Gets Initial OK
Oct 31, 2022
GlobalNewswire
Press Release: Immunomedics : Hagens Berman Sobol Shapiro LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Immunomedics, Inc. Securities - IMMU
Aug 15, 2022
BioSpace
Immunomedics: Everest Medicines Enters into Agreement with Gilead Sciences for Trodelvy in Asia Territories
Dec 03, 2021
BioPharma Dive
Immunomedics: Former Immunomedics executive charged with insider trading around trial data
Nov 27, 2020
Benzinga
Immunomedics: Portnoy Law Firm: Tactile Systems Technology, Inc., Pintec Technologies Holdings Limited, and Immunomedics, Inc. Investors Have Limited Amount of Time Before Class Action Deadline
Nov 16, 2020
Law.com
Press Release: Immunomedics : SHAREHOLDER ALERT: WeissLaw LLP Investigates Immunomedics, Inc.
Oct 23, 2020
FinSMEs
Immunomedics: Gilead Sciences Completes Acquisition of Immunomedics
Oct 20, 2020
FinanzNachrichten
Immunomedics: ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics
Oct 13, 2020
Micro Small Cap
Immunomedics: Immunomedics' Trodelvy Gets Orphan Drug Tag for Glioblastoma
Immunomedics Competitors
1
2
3
4
5
6
7
8
9
10